Protagonist Therapeutics Inc (PTGX)
Current ratio
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Total current assets | US$ in thousands | 591,641 | 355,577 | 237,355 | 340,736 | 315,606 |
| Total current liabilities | US$ in thousands | 47,398 | 21,274 | 31,179 | 44,016 | 40,241 |
| Current ratio | 12.48 | 16.71 | 7.61 | 7.74 | 7.84 |
December 31, 2024 calculation
Current ratio = Total current assets ÷ Total current liabilities
= $591,641K ÷ $47,398K
= 12.48
The current ratio of Protagonist Therapeutics Inc has exhibited a consistently strong liquidity position over the years, as indicated by the values of 7.84, 7.74, and 7.61 for the years 2020, 2021, and 2022 respectively. However, there was a significant increase in the current ratio to 16.71 by December 31, 2023, reflecting a substantial improvement in the company's ability to meet its short-term obligations with current assets. This exceptionally high ratio suggests a robust liquidity position at the end of 2023. The ratio decreased to 12.48 by December 31, 2024, but still indicates a healthy liquidity level. Overall, the trend in the current ratio demonstrates that Protagonist Therapeutics Inc has maintained a sound financial position with ample short-term liquidity throughout the period under review.
Peer comparison
Dec 31, 2024